These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 8621231

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition by 5-fluorouracil of ERCC1 and gamma-glutamylcysteine synthetase messenger RNA expression in a cisplatin-resistant HST-1 human squamous carcinoma cell line.
    Fujishima H, Nakano S, Masumoto N, Esaki T, Tatsumoto T, Kondo T, Niho Y.
    Oncol Res; 1997; 9(4):167-72. PubMed ID: 9268987
    [Abstract] [Full Text] [Related]

  • 3. Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line.
    Esaki T, Nakano S, Tatsumoto T, Kuroki-Migita M, Mitsugi K, Nakamura M, Niho Y.
    Cancer Res; 1992 Dec 01; 52(23):6501-6. PubMed ID: 1423296
    [Abstract] [Full Text] [Related]

  • 4. Schedule-dependent reversion of cisplatin resistance by 5-fluorouracil in a cisplatin-resistant human lung adenocarcinoma cell line A549DDP.
    Zhan M, Liu X.
    Chin Med J (Engl); 1999 Apr 01; 112(4):336-9. PubMed ID: 11593534
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line.
    Tanaka T, Masuda H, Naito M, Tamai H.
    Anticancer Res; 2001 Apr 01; 21(4A):2463-9. PubMed ID: 11724308
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptor.
    Nishikawa K, Rosenblum MG, Newman RA, Pandita TK, Hittelman WN, Donato NJ.
    Cancer Res; 1992 Sep 01; 52(17):4758-65. PubMed ID: 1380890
    [Abstract] [Full Text] [Related]

  • 10. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
    Meijer C, Mulder NH, Hospers GA, Uges DR, de Vries EG.
    Br J Cancer; 1990 Jul 01; 62(1):72-7. PubMed ID: 2390486
    [Abstract] [Full Text] [Related]

  • 11. Circumvention of drug resistance in cisplatin-resistant sublines of the human squamous carcinoma cell line HLac 79 in vitro and in vivo.
    Bier H.
    Acta Otolaryngol; 1991 Jul 01; 111(4):797-806. PubMed ID: 1950544
    [Abstract] [Full Text] [Related]

  • 12. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W, Chaney SG.
    Cancer Res; 1993 Feb 15; 53(4):799-805. PubMed ID: 8428361
    [Abstract] [Full Text] [Related]

  • 13. Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): mechanisms involved in the resistance.
    Beketić-Oresković L, Osmak M, Jaksić M.
    Neoplasma; 1994 Feb 15; 41(3):163-9. PubMed ID: 7935985
    [Abstract] [Full Text] [Related]

  • 14. Epigenetic regulation of chemosensitivity to 5-fluorouracil and cisplatin by zebularine in oral squamous cell carcinoma.
    Suzuki M, Shinohara F, Nishimura K, Echigo S, Rikiishi H.
    Int J Oncol; 2007 Dec 15; 31(6):1449-56. PubMed ID: 17982671
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cytotoxicity of cis-[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(myristato)]-platinum (II) suspended in Lipiodol in a newly established cisplatin-resistant rat hepatoma cell line.
    Kishimoto S, Miyazawa K, Terakawa Y, Ashikari H, Ohtani A, Fukushima S, Takeuchi Y.
    Jpn J Cancer Res; 2000 Dec 15; 91(12):1326-32. PubMed ID: 11123433
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of cis-diamminedichloroplatinum (II)-induced DNA interstrand cross-link removal by 7-ethyl-10-hydroxy-camptothecin in HST-1 human squamous-carcinoma cells.
    Masumoto N, Nakano S, Esaki T, Fujishima H, Tatsumoto T, Niho Y.
    Int J Cancer; 1995 Jul 04; 62(1):70-5. PubMed ID: 7601570
    [Abstract] [Full Text] [Related]

  • 18. Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil.
    Chen CC, Chen LT, Tsou TC, Pan WY, Kuo CC, Liu JF, Yeh SC, Tsai FY, Hsieh HP, Chang JY.
    Br J Cancer; 2007 Aug 06; 97(3):334-44. PubMed ID: 17609664
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
    Lau DH, Lewis AD, Ehsan MN, Sikic BI.
    Cancer Res; 1991 Oct 01; 51(19):5181-7. PubMed ID: 1717140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.